Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month […]
Northstar Group Inc. purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 5,321 shares of the medical research company’s stock, valued at approximately $263,000. Several other large investors have also recently added to or reduced their stakes in EXAS. […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $67.19, for a total transaction of $67,190.00. Following the sale, the executive vice president now owns 86,692 shares in the […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 12,380,000 shares, a decline of 5.3% from the February 28th total of 13,070,000 shares. Based on an average trading volume of 2,510,000 shares, the short-interest ratio is […]
The University of Cape Coast (UCC) has made an urgent appeal for private investments in student residential facilities on campus. The school is grappling with a dire deficit in students’ accommodation, which had forced most students to rent private hostels and homes within the surrounding communities. Consequently, it had recorded…